- ChineseInvestors.com
has become top financial-information website
- The
company is also advancing its cannabidiol program
- CIIX
offers investors multiple revenue streams, healthy return potential
Based in San Gabriel, California, ChineseInvestors.com Inc. (OTCQB: CIIX) offers a
proprietary financial-news media and content platform. The company has become a
foremost financial-information website for Chinese-speaking investors in the
United States and China. Via its main website – www.ChineseInvestors.com –
CIIX offers an array of investor-education products and services. CIIX is also
laying the foundation to capitalize on increasing demand for CBD
(cannabidiol)-based nutrition and health products.
CIIX’s investor-education products and services include
real-time market commentary, analysis and educational-related services in
Chinese-language character sets. The company also provides consultative
services to smaller private companies considering becoming public, as well as
advertising and public-relations-related support services.
As a core element of its services, CIIX features its
exclusive ChineseInvestors Method, an innovative integration of a disciplined
investing process, web-based tools, personalized instructions and invaluable
support. With this strategy, the company provides reliable market information
to assist investors in making informed investment decisions and meeting their
individual financial goals.
CIIX raises investor awareness through investor conferences
and road shows. The company has a subscriber base of free and paying members,
with its base membership – 95% – primarily located in the United States and
Canada. CIIX services are largely delivered to U.S. public and private
companies and U.S. residents and citizens. The company delivers its services in
both traditional and simplified Chinese-language character sets (http://ibn.fm/wFVFL).
CIIX’s CBD initiatives are carried out by its subsidiary,
CBD Biotech Inc. In essence, CIIX is taking advantage of its own financial
expertise to establish itself as a leader in China’s developing CBD industry.
Through CBD Biotech, CIIX has established a three-year development plan to
capitalize on the union of CBD and the nutrition and health products market in
mainland China.
Subsequent to entering into a wholesale agreement with a
well-known CBD health brand in December 2016, CIIX formally launched the
website ChineseCBDOil.com (http://ibn.fm/dtgJL).
This website is one of the world’s first online stores in the Chinese language,
providing industrial-hemp-derived CBD products for Chinese-speaking customers
around the world. Products available on the site include soft gels, capsules
and concentrates. In addition, CIIX opened a retail store in San Gabriel,
California, which has a high Chinese population.
Of note to investors is that CIIX CEO Warren Wang has said
the company is planning an IPO of wholly owned CBD Biotech. In the
announcement, Wang noted that CIIX hopes for a Nasdaq IPO of CBD Biotech early
in 2020. CIIX would then concentrate on identifying an acquisition target for
further growth (http://ibn.fm/I1iRR).
CIIX continues to focus on providing premier financial
information via its main website. At the same time, the company is leveraging
the opportunity for significant revenue streams through its CBD Biotech
subsidiary. For investors, CIIX offers a two-pronged business strategy for a
healthy return on investment.
For more information, visit the company’s website at www.ChineseInvestors.com
NOTE TO INVESTORS: The latest news and updates
relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
